|Day Low/High||2.25 / 2.26|
|52 Wk Low/High||2.21 / 8.77|
Here's what you need to know now for Thursday, August 17.
The much smaller asset purchase they are now attempting should not raise the kinds of concerns the commission had about the original merger, they argue.
RediClinic, a leading operator of convenient care clinics, is offering back-to-school physical exams and vaccinations in all locations, helping busy parents and students meet school requirements for vaccinations and good...
The deal is worth $1.4 billion and PharMerica's board has already given it the green light.
School bells will soon be ringing, signaling the start of a new school year and the second-busiest shopping season, according to the National Retail Federation.
In an effort to help patients looking to protect themselves against the flu, Rite Aid announced today the availability of seasonal flu shots at Rite Aid pharmacies across the country.
Updating members on a few other items that we are keeping an eye on.
No one knows where the giant squid is going to strike next.
Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.
Earnings help boost markets as D.C. isn't counted on for much of anything. Portfolio action (it was a busy week) includes a new position and a downgrade.
Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 360 pharmacies in Michigan and South Carolina without a prescription, subject...
We're selling our shares in Walgreens as our bullish thesis has lost its luster.
The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.
It was the seventh best performer in the index during the first half of the year.
The chess game continues.
Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.
BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
One Wall Street firm thinks it's a real possibility.
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
Oxford sleep researcher Russell Foster argues that smartphone addiction is compromising the sleep time an average teenager is getting.
Analysts at Berenberg say traditional automakers remain complacent about electric vehicles.
Uber thanked the dedication of the drivers making those trips possible and awarded each $500.
The firm expects the company to lower its labor costs and increase sales.
Drones to the rescue!